The significant outperformance of IDEXX Laboratories over the past 5 years, as highlighted by its average annual return of 16.57% and a market capitalization of $41.47 billion, indicates a strong and stable growth trajectory. This performance, especially in comparison to the broader market, suggests a positive outlook for IDXX in the short term, assuming no major market shifts or company-specific setbacks occur.